Jennifer R. Cracchiolo

Jennifer R. Cracchiolo

Auto-generated profile, based on publicly available information

Jennifer R. Cracchiolo

Department of Surgery Memorial Sloan Kettering Cancer Center New York New York USA

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 May 2017 in Antioxidants & Redox Signaling
Verified
Journal Article
Closed access
NANaïma Azouzi
Naïma Azouzi
JCJérémy Cailloux
Jérémy Cailloux
JMJuliana Cazarin de Menezes
Juliana Cazarin de Menezes
JKJeffrey A. Knauf
Jeffrey A. Knauf
JCJennifer Cracchiolo
Jennifer Cracchiolo
CDCorinne Dupuy
Corinne Dupuy
Aims: The BRAFV600E oncogene, reported in 40-60% of papillary thyroid carcinoma (PTC), has an important role in the pathogenesis of PTC. It is associated with the loss of thyroid iodide-metabolizing genes, such as sodium/iodide symporter (NIS) and therefore with radioiodide-refractoriness. Inhibition of MAPK pathway, constitutively activated by BRAFV600E, is not always efficient in resistant tumors suggesting that other compensatory mechanisms contribute to a BRAFV600E adaptive resistance. Recent studies pointed to a key role of TGF-β in BRAFV600E-induced effects. The reactive oxygene species (ROS)-generating NADPH oxidase NOX4, which is increased in PTC, has been identified as a new key effector of TGF-β in cancer, suggestive of a potential role in BRAFV600E-induced thyroid tumors. Results: Here, using two human BRAFV600E mutated thyroid cell lines and a rat thyroid cell line expressing BRAFV600E in a conditional manner we show that NOX4 up-regulation is controlled at the transcriptional level by the oncogene via the TGF-β/Smad3 signaling pathway. Importantly, treatment of cells with NOX4-targeted siRNA downregulates BRAFV600E-induced NIS repression. Innovation and Conclusion: Our results establish a link between BRAFV600E and NOX4, which is confirmed by a comparative analysis of NOX4 expression in human (TCGA) and mouse thyroid cancers. Remarkably, analysis of human and murine BRAFV600E-mutated thyroid tumors highlights that the level of NOX4 expression is inversely correlated to thyroid differentiation suggesting that other genes involved in thyroid differentiation in addition to NIS might be silenced by a mechanism controlled by NOX4-derived ROS. This study opens a new opportunity to optimize thyroid cancer therapy

9 March 2018 in Head & Neck
Verified
Journal Article
Closed access
PDF file
JCJennifer R. Cracchiolo
Jennifer R. Cracchiolo
BXBin Xu
Bin Xu
JMJocelyn C. Migliacci
Jocelyn C. Migliacci
NKNora Katabi
Nora Katabi
DPDavid G. Pfister
David G. Pfister
RWRichard J. Wong
Richard J. Wong

30 November 2018 in Cancer
Verified
Journal Article
Closed access
PDF file
JCJennifer R. Cracchiolo
Jennifer R. Cracchiolo
AKAnne F. Klassen
Anne F. Klassen
DYDanny A. Young‐Afat
Danny A. Young‐Afat
CAClaudia R. Albornoz
Claudia R. Albornoz
SCStefan J. Cano
Stefan J. Cano
EMEvan Matros
Evan Matros

1 April 2016 in Otolaryngologic Clinics of North America
Verified
Journal Article
Closed access
JCJennifer R. Cracchiolo
Jennifer R. Cracchiolo
ASAshok R. Shaha
Ashok R. Shaha

22 November 2018 in Journal of Surgical Oncology
Verified
Journal Article
Closed access
PDF file
RJRohan R. Joshi
Rohan R. Joshi
QHQasim Husain
Qasim Husain
BRBenjamin R. Roman
Benjamin R. Roman
JCJennifer Cracchiolo
Jennifer Cracchiolo
YYYao Yu
Yao Yu
MCMarc A Cohen
Marc A Cohen

28 November 2017 in Journal of Surgical Oncology
Verified
Journal Article
Closed access
PDF file
JCJennifer R. Cracchiolo
Jennifer R. Cracchiolo
KPKrupa Patel
Krupa Patel
JMJocelyn C. Migliacci
Jocelyn C. Migliacci
LMLuc T. Morris
Luc T. Morris
IGIan Ganly
Ian Ganly
MCMarc A Cohen
Marc A Cohen